Search research articles
Contact Us
Filters
Showing results (11-20 of 13) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 13 results.
Journal of Pediatric Gastroenterology and Nutrition
|
October 30, 2015
Should Partial Hydrolysates Be Used as Starter Infant Formula? A Working Group Consensus
Yvan Vandenplas, Pedro Alarcon, David Fleischer, et al.
Nature Genetics
|
February 28, 2018
Human TGF-β1 deficiency causes severe inflammatory bowel disease and encephalopathy
Daniel Kotlarz, Benjamin Marquardt, Tuva Barøy, et al.
The Lancet. Gastroenterology & Hepatology
|
April 26, 2024
Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial
Nadia Ovchinsky, Madeleine Aumar, Alastair Baker, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 13) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 13 results.
Journal of Pediatric Gastroenterology and Nutrition
|
October 30, 2015
Should Partial Hydrolysates Be Used as Starter Infant Formula? A Working Group Consensus
Yvan Vandenplas, Pedro Alarcon, David Fleischer, et al.
Nature Genetics
|
February 28, 2018
Human TGF-β1 deficiency causes severe inflammatory bowel disease and encephalopathy
Daniel Kotlarz, Benjamin Marquardt, Tuva Barøy, et al.
The Lancet. Gastroenterology & Hepatology
|
April 26, 2024
Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial
Nadia Ovchinsky, Madeleine Aumar, Alastair Baker, et al.
Page
of 2